C-level executive helping great companies streamline their strategic approaches while rapidly and successfully developing Biologics. Decades of experience in end to end medical therapeutic, drug, device, biologics, and combination products. Excited to be building solid value at Ankasa Regenerative Therapeutics developing wnt3A for a multitude of indications. Recruited by MiMedx to transform a high growth public company from a tissue product distributor to a data driven Biopharma company. Recently Chief Medical Officer at Histogenics, a pre-revenue public regenerative medicine company directing Clinical, Medical Affairs, R&D, Regulatory, and Pharmacovigilance activities. Actively consulting on launch prep and early commercialization strategies, as well as securing corporate funding. Formerly Senior Director at one of the top 4 largest multinational pharmaceutical companies in the world with strategic responsibility for global R&D organization.
C-level executive helping great companies streamline their strategic approaches while rapidly and successfully developing Biologics. Decades of experience in end to end medical therapeutic, drug, device, biologics, and combination products. Excited to be building solid value at Ankasa Regenerative Therapeutics developing wnt3A for a multitude of indications. Recruited by MiMedx to transform a high growth public company from a tissue product distributor to a data driven Biopharma company. Recently Chief Medical Officer at Histogenics, a pre-revenue public regenerative medicine company directing Clinical, Medical Affairs, R&D, Regulatory, and Pharmacovigilance activities. Actively consulting on launch prep and early commercialization strategies, as well as securing corporate funding. Formerly Senior Director at one of the top 4 largest multinational pharmaceutical companies in the world with strategic responsibility for global R&D organization.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy